{"id":57687,"date":"2024-02-27T17:55:39","date_gmt":"2024-02-27T17:55:39","guid":{"rendered":"https:\/\/medsname.com\/novorapid-flexpen\/"},"modified":"2026-04-30T10:24:23","modified_gmt":"2026-04-30T10:24:23","slug":"novorapid-flexpen","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/novorapid-flexpen\/","title":{"rendered":"Novorapid Flexpen"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 R\u0103spuns rapid \u2014 Ce este NovoRapid FlexPen?<\/h3>\n<p style=\"margin:0;\"><strong>NovoRapid FlexPen<\/strong> este un stilou de insulin\u0103 prefabricat \u0219i de unic\u0103 folosin\u021b\u0103 care con\u021bine <strong>insulin aspart<\/strong> (100 unit\u0103\u021bi\/mL, stilou de 3 mL) \u2014 un <strong>analog rapid de insulin\u0103<\/strong> utilizat\u0103 la timpul meselor (insulin\u0103 bolus) \u00een diabetul de tip 1 \u0219i tip 2. Are un debut de ac\u021biune de 10\u201315 minute, efect maxim la 1\u20133 ore \u0219i o durat\u0103 total\u0103 de 3\u20135 ore. Se administreaz\u0103 subcutanat \u00een abdomen, coaps\u0103 sau bra\u021b, cu 5\u201315 minute \u00eenainte de mas\u0103 (sau imediat dup\u0103 pentru persoanele cu obiceiuri alimentare imprevizibile). Doza uzual\u0103: 0,5\u20131 unitate la fiecare 10 g de carbohidra\u021bi, adaptat\u0103 individual \u00een func\u021bie de glicemie, aportul de carbohidra\u021bi \u0219i sensibilitatea la insulin\u0103. <strong>Principalul risc: hipoglicemie.<\/strong> Se folose\u0219te \u00eempreun\u0103 cu o insulin\u0103 bazal\u0103 (cu ac\u021biune prelungit\u0103) \u00een diabetul de tip 1 sau \u00een combina\u021bie cu medicamente orale sau insulin\u0103 bazal\u0103 \u00een diabetul de tip 2. Stocare: stilourile nefolosite la 2\u20138\u00b0C; dup\u0103 deschidere, se p\u0103streaz\u0103 la temperatura camerei &lt; 30\u00b0C pentru maximum 28 de zile.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Medicamentele noastre generice sunt procurate de la produc\u0103tori certifica\u021bi WHO-GMP \u0219i expediate la nivel mondial \u00een ambalaje discrete \u0219i simple \u2014 f\u0103r\u0103 denumirea medicamentului pe exteriorul coletului. Pl\u0103\u021bile cu cardul sunt procesate printr-un procesor reglementat (descrierile de pe extrasul de cont includ un procesor de pl\u0103\u021bi cu card reglementat \u2014 niciodat\u0103 \u201cMedsBase\u201d sau numele vreunui medicament). Accept\u0103m \u0219i criptomonede \u0219i transferuri bancare SEPA. Fiecare comand\u0103 este sus\u021binut\u0103 de Politica noastr\u0103 de Asigurare pentru Relivrare.<\/p>\n<div style=\"background:#f4f8fb;border-left:4px solid #2c7cb0;padding:16px 20px;margin:0 0 24px 0;border-radius:4px;font-size:14px;\"><strong>\ud83d\udcc5 De ce s\u0103 comanzi NovoRapid FlexPen de la MedsBase?<\/strong> Stoc original de la produc\u0103torul Novo Nordisk \u00b7 transport protejat termic pentru insulin\u0103 \u00b7 livrare la nivel mondial \u00b7 peste 1.400 de clien\u021bi din peste 50 de \u021b\u0103ri \u00b7 evaluare 4,9\u2605. <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">Citeste recenziile clientilor<\/a>.<\/div>\n<h2 class=\"wp-block-heading\">Ce este NovoRapid FlexPen?<\/h2>\n<p>NovoRapid FlexPen este un pen prefabricat, de unic\u0103 folosin\u021b\u0103, care con\u021bine 3 mL (300 de unit\u0103\u021bi) de insulin\u0103 aspart, reglabil la 1\u201360 de unit\u0103\u021bi pe doz\u0103 \u00een trepte de 1 unitate. Con\u021bine insulin\u0103 aspart (100 unit\u0103\u021bi\/mL, pen de 3 mL) fabricat\u0103 de Novo Nordisk, furnizat\u0103 \u00een cutii cu 1 sau 5 penuri prefabricate.<\/p>\n<p>insulin\u0103 aspart este o <strong>analog rapid de insulin\u0103<\/strong> \u2014 o insulin\u0103 de mas\u0103 (\u201cbolus\u201d) utilizat\u0103 pentru a corespunde cre\u0219terii glicemiei postprandiale. NovoRapid (NovoLog \u00een SUA) este marca original\u0103 la nivel mondial.<\/p>\n<h2 class=\"wp-block-heading\">Cum func\u021bioneaz\u0103 NovoRapid FlexPen?<\/h2>\n<p>Insulina este hormonul natural eliberat de pancreas dup\u0103 mese pentru a ajuta celulele s\u0103 absoarb\u0103 glucoz\u0103. \u00cen diabet, acest r\u0103spuns insulinic este fie absent (tip 1), fie insuficient (tip 2). Injectiile de insulin\u0103 bolus \u00eenlocuiesc acest r\u0103spuns.<\/p>\n<p>Insulina aspart este ob\u021binut\u0103 prin \u00eenlocuirea unei proline cu acid aspartic la pozi\u021bia B28 a insulinei umane, ceea ce previne aglomerarea moleculelor de insulin\u0103 \u00een hexamere \u2014 astfel \u00eenc\u00e2t acestea se disociaz\u0103 \u0219i se absorb mai repede dec\u00e2t insulina uman\u0103 obi\u0219nuit\u0103. Acest lucru confer\u0103 un profil farmacocinetic adaptat cre\u0219terii glicemiei la timpul meselor:<\/p>\n<ul>\n<li><strong>\u00cenceputul ac\u021biunii:<\/strong> 10\u201315 minute<\/li>\n<li><strong>Efect maxim:<\/strong> 1\u20133 ore<\/li>\n<li><strong>Durat\u0103 total\u0103:<\/strong> 3\u20135 ore<\/li>\n<\/ul>\n<p>Acest profil imit\u0103 \u00eendeaproape eliberarea fiziologic\u0103 de insulin\u0103 postprandial\u0103 \u2014 mult mai bine dec\u00e2t insulina uman\u0103 obi\u0219nuit\u0103, care are un debut lent de 30 de minute \u0219i o coad\u0103 lung\u0103 de 6\u20138 ore care poate provoca hipoglicemie tardiv\u0103.<\/p>\n<h2 class=\"wp-block-heading\">Doza \u0219i administrare<\/h2>\n<p><strong>Momentul administr\u0103rii:<\/strong> injecta\u021bi 5\u201315 minute \u00eenainte de fiecare mas\u0103. Dac\u0103 momentul mesei este imprevizibil (copii mici, adul\u021bi bolnavi), injectarea chiar \u00eenainte sau chiar imediat dup\u0103 mas\u0103 este acceptabil\u0103 \u2014 aceast\u0103 flexibilitate este un avantaj cheie al analogilor cu ac\u021biune rapid\u0103 fa\u021b\u0103 de insulina obi\u0219nuit\u0103.<\/p>\n<p><strong>Doza:<\/strong> individualizat pentru pacient. Abord\u0103ri comune de \u00eenceput:<\/p>\n<ul>\n<li><strong>Regim cu doz\u0103 fix\u0103:<\/strong> 4\u20136 unit\u0103\u021bi \u00eenainte de fiecare mas\u0103 principal\u0103<\/li>\n<li><strong>Num\u0103rarea carbohidra\u021bilor:<\/strong> 0,5\u20131 unitate la fiecare 10 g de carbohidra\u021bi din mas\u0103 (raport insulin\u0103-carbohidra\u021bi; individualizat)<\/li>\n<li><strong>Doza de corec\u021bie:<\/strong> ad\u0103uga\u021bi 1 unitate pentru fiecare 2,5\u20133 mmol\/L (45\u201354 mg\/dL) peste nivelul glucozei \u021bint\u0103 (factor de sensibilitate; individualizat)<\/li>\n<\/ul>\n<p><strong>Tehnica de injectare:<\/strong><\/p>\n<ul>\n<li>Injecta\u021bi subcutan \u00een <strong>abdomen, partea frontal\u0103 a coapsei, partea superioar\u0103 extern\u0103 a bra\u021bului sau partea superioar\u0103 extern\u0103 a feselor.<\/strong>. Absorb\u021bia este cea mai rapid\u0103 din abdomen.<\/li>\n<li>Rota\u021bi locurile de injectare \u00een aceea\u0219i zon\u0103 pentru a preveni <strong>lipohipertrofia<\/strong> (proeminen\u021be sub piele care fac absorb\u021bia erratic\u0103).<\/li>\n<li>Folosi\u021bi un ac nou de pen pentru fiecare doz\u0103.<\/li>\n<li>\u00centotdeauna <strong>preg\u0103ti\u021bi stiloul<\/strong> cu 2 unit\u0103\u021bi \u00eenainte de a selecta doza (verifica\u021bi dac\u0103 apare un fir de insulin\u0103 la v\u00e2rf).<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Efecte Secundare<\/h2>\n<p><strong>Cel mai important:<\/strong><\/p>\n<ul>\n<li><strong>Hipoglicemie<\/strong> \u2014 principalul risc al oric\u0103rui insulin. Simptome: tremur\u0103turi, transpira\u021bie, foame, palpita\u021bii, confuzie. Trata\u021bi cu 15 g de carbohidra\u021bi cu ac\u021biune rapid\u0103 (comprimate de glucoz\u0103, suc), apoi o gustare cu carbohidra\u021bi complec\u0219i.<\/li>\n<li><strong>Cre\u0219terea \u00een greutate<\/strong> \u2014 1\u20133 kg \u00een medie \u00een primul an.<\/li>\n<\/ul>\n<p><strong>Local:<\/strong><\/p>\n<ul>\n<li>Reac\u021bii la locul de injectare: ro\u0219ea\u021b\u0103, m\u00e2nc\u0103rime, v\u00e2n\u0103t\u0103i<\/li>\n<li>Lipohipertrofie din cauza inject\u0103rilor repetate \u00een acela\u0219i loc<\/li>\n<li>Lipoatrofie rar\u0103 (sub\u021bierea \u021besutului adipos subcutanat)<\/li>\n<\/ul>\n<p><strong>Pu\u021bin frecvente, dar importante:<\/strong><\/p>\n<ul>\n<li>Hipokaliemie (nivel sc\u0103zut de potasiu) \u2014 mai ales la corectarea rapid\u0103 a hiperglicemiei sau \u00een tratamentul CAD<\/li>\n<li>Reten\u021bie de lichide, edem periferic (de obicei u\u0219or)<\/li>\n<li>Hipersensibilitate, rareori anafilaxie<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Interac\u021biuni medicamentoase<\/h2>\n<p><strong>Factori care cresc riscul de hipoglicemie:<\/strong> sulfoniluree, meglitinide, inhibitori ACE, disopiramid\u0103, fibrate, fluoxetin\u0103, IMAO, pentoxifilin\u0103, propoxifen, salicila\u021bi, antibiotice sulfamidice, analogi de somatostatin\u0103, alcool.<\/p>\n<p><strong>Reduc efectul insulinei:<\/strong> corticoesteroizi, contraceptive orale, tiazide, hormoni tiroidieni, simpatomimetice, antipsihotice atipice, izoniazid\u0103, niacin\u0103, danazol, inhibitori de proteaz\u0103.<\/p>\n<p><strong>Variabil:<\/strong> beta-blocante (mascheaz\u0103 simptomele hipoglicemiei), litiu, octreotid\u0103.<\/p>\n<h2 class=\"wp-block-heading\">Cine nu ar trebui s\u0103 foloseasc\u0103 NovoRapid FlexPen?<\/h2>\n<ul>\n<li>Episod actual de hipoglicemie<\/li>\n<li>Hipersensibilitate cunoscut\u0103 la insulin\u0103 aspart sau la orice excipient<\/li>\n<li>Cetoacidoz\u0103 diabetic\u0103 \u2014 doar \u00een medii supravegheate cu insulin\u0103 intravenoas\u0103 \u0219i fluide<\/li>\n<\/ul>\n<p><strong>\u00cen timpul sarcinii:<\/strong> analogii cu ac\u021biune rapid\u0103 sunt considera\u021bi compatibili \u0219i utiliza\u021bi pe scar\u0103 larg\u0103. Discuta\u021bi cu echipa dumneavoastr\u0103 de diabetologie obstetric\u0103.<\/p>\n<p><strong>Utilizare pediatric\u0103:<\/strong> at\u00e2t NovoRapid c\u00e2t \u0219i Apidra sunt aprobate pentru utilizare la copii (Apidra de la 4 ani, NovoRapid de la 1 an) cu dozaj pediatric adecvat.<\/p>\n<h2 class=\"wp-block-heading\">Depozitare \u0219i Manipulare<\/h2>\n<ul>\n<li><strong>Pensuri nefolosite:<\/strong> p\u0103stra\u021bi la frigider la 2\u20138\u00b0C p\u00e2n\u0103 la data de expirare. Nu congela\u021bi.<\/li>\n<li><strong>Pensuri \u00een uz (dup\u0103 prima injec\u021bie):<\/strong> p\u0103stra\u021bi la temperatura camerei (sub 30\u00b0C), departe de c\u0103ldur\u0103 direct\u0103 \u0219i lumin\u0103 solar\u0103. Arunca\u021bi dup\u0103 28 de zile \u2014 chiar dac\u0103 mai r\u0103m\u00e2ne insulin\u0103.<\/li>\n<li>Nu utiliza\u021bi dac\u0103 insulina este tulbure, decolorat\u0103 sau con\u021bine particule.<\/li>\n<li>Nu folosi\u021bi acela\u0219i stilou \u00eentre pacien\u021bi, nici m\u0103car cu un ac nou.<\/li>\n<li>Purta\u021bi \u00eentotdeauna un stilou de rezerv\u0103 \u0219i tablete de glucoz\u0103 c\u00e2nd sunte\u021bi plecat de acas\u0103.<\/li>\n<\/ul>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3 class=\"wp-block-heading\">Este NovoRapid acela\u0219i lucru cu insulin\u0103 aspart sau NovoLog?<\/h3>\n<p>Da. NovoRapid (utilizat \u00een majoritatea \u021b\u0103rilor) \u0219i NovoLog (utilizat \u00een SUA \u0219i Canada) sunt acela\u0219i medicament \u2014 insulin\u0103 aspart 100 unit\u0103\u021bi\/mL \u2014 fabricat de Novo Nordisk. Denumirile comerciale diferite sunt datorate marketingului regional, nu unor formul\u0103ri diferite.<\/p>\n<h3 class=\"wp-block-heading\">C\u00e2nd ar trebui s\u0103 injectez NovoRapid FlexPen \u2014 \u00eenainte sau dup\u0103 mas\u0103?<\/h3>\n<p>5\u201315 minute \u00eenainte de mas\u0103 este standard \u0219i ofer\u0103 cel mai bun control al glicemiei. Injectarea chiar \u00eenainte sau imediat dup\u0103 mas\u0103 este acceptabil\u0103 atunci c\u00e2nd momentul mesei este imprevizibil \u2014 pentru copii mici, persoanele cu gastroparez\u0103 sau atunci c\u00e2nd nu \u0219ti\u021bi \u00eenc\u0103 c\u00e2t ve\u021bi m\u00e2nca. Injectarea mult mai t\u00e2rziu reduce controlul asupra cre\u0219terii glicemiei postprandiale.<\/p>\n<h3 class=\"wp-block-heading\">Ce se \u00eent\u00e2mpl\u0103 dac\u0103 injectez accidental prea mult?<\/h3>\n<p>Consuma\u021bi imediat un carbohidrat cu ac\u021biune rapid\u0103 (15 g de glucoz\u0103), apoi o gustare cu ac\u021biune mai lent\u0103 (p\u00e2ine, biscui\u021bi, sandvi\u0219) pentru a acoperi ac\u021biunea continu\u0103 a insulinei \u00een urm\u0103toarele 3\u20135 ore. Verifica\u021bi glicemia la fiecare 15\u201330 de minute. Hipoglicemia sever\u0103 sau care nu r\u0103spunde necesit\u0103 glucagon sau ajutor medical.<\/p>\n<h3 class=\"wp-block-heading\">Am nevoie \u0219i de insulin\u0103 bazal\u0103 (cu ac\u021biune prelungit\u0103)?<\/h3>\n<p>\u00cen cazul diabetului zaharat de tip 1 \u2014 da, \u00eentotdeauna. Insulina rapid\u0103 singur\u0103 nu poate asigura acoperire bazal\u0103 pe 24 de ore, iar \u00eentreruperea insulinei cu ac\u021biune prelungit\u0103 \u00een diabetul zaharat de tip 1 provoac\u0103 cetoacidoz\u0103 diabetic\u0103 \u00een c\u00e2teva ore. \u00cen cazul diabetului zaharat de tip 2, NovoRapid FlexPen este adesea utilizat \u00eempreun\u0103 cu insulin\u0103 bazal\u0103 (glargin\u0103, degludec) \u0219i medicamente orale.<\/p>\n<h3 class=\"wp-block-heading\">Pot s\u0103 amestec NovoRapid FlexPen cu insulin\u0103 cu ac\u021biune prelungit\u0103 \u00een aceea\u0219i sering\u0103?<\/h3>\n<p>Nu \u2014 analogii cu ac\u021biune rapid\u0103 nu trebuie amesteca\u021bi cu analogii cu ac\u021biune prelungit\u0103 (glargin\u0103, degludec, detemir) \u00een aceea\u0219i sering\u0103. Folosi\u021bi injec\u021bii separate. Le pute\u021bi administra \u00een acela\u0219i timp cu penuri diferite.<\/p>\n<h3 class=\"wp-block-heading\">Poate fi utilizat NovoRapid FlexPen \u00een pompe de insulin\u0103?<\/h3>\n<p>Da \u2014 analogii cu ac\u021biune rapid\u0103, inclusiv aspart \u0219i glulisin\u0103, sunt insulinile standard pentru pompele de perfuzare subcutanat\u0103 continu\u0103 (CSII). Cere\u021bi recomand\u0103ri specifice pompei de la echipa dumneavoastr\u0103 de diabetologie.<\/p>\n<h3 class=\"wp-block-heading\">Expir\u0103 NovoRapid FlexPen odat\u0103 ce stiloul este \u00een uz?<\/h3>\n<p>Da \u2014 dup\u0103 prima injec\u021bie, penul este valabil 28 de zile la temperatura camerei (sub 30\u00b0C). Arunca\u021bi-l \u00een ziua 29, chiar dac\u0103 mai r\u0103m\u00e2ne insulin\u0103. Nota\u021bi data de \u00eenceput pe pen.<\/p>\n<h3 class=\"wp-block-heading\">Unde pot cump\u0103ra NovoRapid FlexPen online?<\/h3>\n<p>Pute\u021bi comanda NovoRapid FlexPen (100 unit\u0103\u021bi\/mL, stilou de 3 mL) de la MedsBase \u00een pachete de 1 sau 5 stilouri preumplute. Insulina este expediat\u0103 cu ambalaj termoprotejat; livrare la nivel mondial. Ambalaj discret \u0219i stoc original de la produc\u0103torul Novo Nordisk.<\/p>\n<h2 class=\"wp-block-heading\">Medicamente \u00eenrudite pentru Diabet<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/novorapid-flexpen\/\">NovoRapid FlexPen \u2014 Insulin\u0103 aspart (ac\u021biune rapid\u0103)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/apidra-solostar\/\">Apidra SoloStar \u2014 Insulin\u0103 glulisin\u0103 (ac\u021biune rapid\u0103)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/glycomet-sr\/\">Glycomet SR \u2014 Metformin\u0103 (linie primar\u0103 oral\u0103)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/januvia\/\">Januvia \u2014 Sitagliptin\u0103 (inhibitor DPP-4)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/jardiance-empagliflozin\/\">Jardiance \u2014 Empagliflozin\u0103 (inhibitor SGLT-2)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/diabetes-medication\/\"><strong>Vizualiza\u021bi toate Medicamentele pentru Diabet<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 Dezaprobare medical\u0103.<\/strong> Aceast\u0103 pagin\u0103 are doar scop informativ \u0219i nu \u00eenlocuie\u0219te sfatul medical al unui profesionist calificat \u00een domeniul s\u0103n\u0103t\u0103\u021bii. Terapia cu insulin\u0103 necesit\u0103 dozaj individualizat \u0219i monitorizare atent\u0103 a glicemiei \u2014 utiliza\u021bi-o \u00eentotdeauna sub \u00eendrumarea unui specialist \u00een diabet \u0219i purta\u021bi carbohidra\u021bi cu ac\u021biune rapid\u0103 pentru a trata hipoglicemia.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Alternative conexe<\/h3>\n<p>Alte produse din <strong>Afec\u021biuni cronice<\/strong> pe care clien\u021bii le vizualizeaz\u0103 de asemenea:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/voveran-emulgel\/\">Voveran Emulgel<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/d-mine\/\">D-mine<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/beclate-inhaler\/\">Beclate Inhaler<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/noltrexate\/\">Noltrexate<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/atrest\/\">Atrest<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Control rapid al glicemiei<br \/>\n\u2705 Design convenabil al penului<br \/>\n\u2705 Dozaj reglabil<br \/>\n\u2705 Risc redus de hipoglicemie<br \/>\n\u2705 Auto-administrare simpl\u0103<\/p>\n<p>Novorapid Flexpen con\u021bine insulin\u0103.<\/p>","protected":false},"featured_media":57688,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3230,3231],"product_tag":[4343,4348],"class_list":{"0":"post-57687","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-diabetes","9":"product_cat-diabetes-medication","10":"product_tag-insulin","11":"product_tag-novorapid-flexpen","13":"first","14":"instock","15":"shipping-taxable","16":"purchasable","17":"product-type-variable","18":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/57687","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=57687"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/57688"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=57687"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=57687"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=57687"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=57687"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}